Ozempic hypoglycemia risk — low risk alone, but real risk when combined with insulin or sulfonylureas. Symptoms, management, and what the label says.
Short answer: Ozempic alone rarely causes hypoglycemia — its insulin release is glucose-dependent (it only acts when sugar is high). The real risk is combination use: add insulin or a sulfonylurea and hypoglycemia becomes common, which is why the label often reduces the other drug's dose.
Symptoms of low blood sugar
- Shakiness, sweating
- Hunger, irritability, confusion
- Rapid heartbeat
- Dizziness, blurred vision
- Severe: fainting, seizures — emergency
The combination risk
Alone, Ozempic's hypoglycemia rate is low (it's glucose-dependent). Combined with insulin or sulfonylureas, rates rise sharply — the label specifically instructs reducing the other drug when adding semaglutide.
If it happens
15g fast sugar (glucose tabs, juice, sugar water), recheck in 15 min, repeat if still low, then a snack. Severe episodes with confusion/unconsciousness — emergency care.
Rarely — its action is glucose-dependent. Risk is mainly when combined with insulin or sulfonylureas.
If on combination therapy — glucose tabs or juice. Tell your doctor about any lows; doses may need adjustment.
FDA label — hypoglycemia section; combination-therapy trial data.